You are here

  • Home
  • Archive
  • Volume 28, Issue Suppl 1
  • 3PC-071 Fully automated central intravenous additive service (CIVAS): a 12 month analysis of performances and impact of COVID-19 on sterile antibiotic production

Article info

Article menu

Download PDFPDF

Section 2: Selection, procurement and distribution
3PC-071 Fully automated central intravenous additive service (CIVAS): a 12 month analysis of performances and impact of COVID-19 on sterile antibiotic production
Free

Authors

Citation

Vagnoni F, Leoni S, Guglielmi S, et al
3PC-071 Fully automated central intravenous additive service (CIVAS): a 12 month analysis of performances and impact of COVID-19 on sterile antibiotic production
European Journal of Hospital Pharmacy 2021;28:A22.

Publication history

  • First published March 14, 2021.
Online issue publication 
March 15, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.